In preclinical studies, inhibition of AGE formation, or interventions that break their cross-linked structure, have been shown to delay the development of nephropathy, even without directly impacting blood sugar control (Forbes 2003)
Enhances focus and emotional balance by restoring neuronal energy
Using only M54.50 may not support advanced imaging orders
The average STEP 1 participant lost roughly two-thirds of their total weight in the first 36 weeks
3) and without CKD (RR 0.88, 95% CI 0.641.20
Nausea is the most common first-week side effect, affecting up to 44% of patients on higher doses, alongside bloating, constipation, or diarrhoea, which typically diminish over 24 weeks